Effect of pituitary and ovarian hormones on human melanocytes in vitro.

Normal human melanocytes in culture became enlarged and dendritic after a 2-day incubation with either the pituitary (beta-MSH, a potent analog of alpha-MSH, ACTH, FSH and LH) or the ovarian (estradiol, estriol and progesterone) hormones. Under the same experimental conditions, pituitary hormones also increased both the tyrosinase activity and tyrosinase-related protein-1 (TRP-1) while ovarian hormones increased TRP-1 but not tyrosinase activity. The results suggest that pituitary and ovarian hormones possibly induce hyperpigmentation of the skin by stimulating the melanogenesis in epidermal melanocytes, and that estradiol and progesterone may be involved in the pathogenesis of melasma (chloasma) usually developing between early adulthood and menopause in which a high concentration of serum ovarian hormones was maintained.

[1]  S. Boyce,et al.  Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Lunec,et al.  Cultured human melanocytes respond to MSH peptides and ACTH. , 1994, Pigment cell research.

[3]  G. Imokawa,et al.  DHICA oxidase activity of TRP1 and interactions with other melanogenic enzymes. , 1994, Pigment cell research.

[4]  H. Tagami,et al.  Effects of staurosporine, PMA and A23187 on human melanocyte cultures with dibutyryl cyclic AMP , 1992, The British journal of dermatology.

[5]  S. Shibahara,et al.  The monoclonal antibodies TMH-1 and TMH-2 specifically bind to a protein encoded at the murine b-locus, not to the authentic tyrosinase encoded at the c-locus. , 1991, The Journal of investigative dermatology.

[6]  I. Jackson,et al.  The molecular basis of brown, an old mouse mutation, and of an induced revertant to wild type. , 1990, Genetics.

[7]  S. Shibahara,et al.  Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. , 1990, Nucleic acids research.

[8]  R. Mason,et al.  Human Melanocytes as a Target Tissue for Hormones: In Vitro Studies with 1α-25, dihydroxyvitamin D3, α-melanocyte Stimulating Hormone, and Beta-estradiol , 1988 .

[9]  G. Schütz,et al.  Functional analysis of alternatively spliced tyrosinase gene transcripts. , 1988, The EMBO journal.

[10]  I. Jackson,et al.  A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Tagami,et al.  Stimulatory effect of prostaglandin E2 on the configuration of normal human melanocytes in vitro. , 1987, The Journal of investigative dermatology.

[12]  S. Shibahara,et al.  Cloning and expression of cDNA encoding mouse tyrosinase. , 1986, Nucleic acids research.

[13]  V. Hearing,et al.  Monoclonal antibodies produced against murine tyrosinase identify pigmented human melanocytes. , 1986, Diagnostic immunology.

[14]  Pawelek Jm.  Studies on the Cloudman melanoma cell line as a model for the action of MSH. , 1985 .

[15]  V. Hearing,et al.  Anti-T4-tyrosinase monoclonal antibodies--specific markers for pigmented melanocytes. , 1985, The Journal of investigative dermatology.

[16]  H. Tagami,et al.  Efficient culturing of human melanocytes from suction blisters. , 1985, Tohoku journal of experimental medicine.

[17]  F. Aguiló,et al.  Endocrinologic profile of patients with idiopathic melasma. , 1983, The Journal of investigative dermatology.

[18]  S. Pomerantz,et al.  Regulation of tyrosinase in human melanocytes grown in culture , 1983, The Journal of cell biology.

[19]  M. Mihm,et al.  Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. , 1981, Journal of the American Academy of Dermatology.

[20]  V. Hruby,et al.  4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Seiji,et al.  Transfer mechanism of melanosomes in epidermal cell culture. , 1976, The Journal of investigative dermatology.

[22]  A. Tanay,et al.  The effect of alpha-methyldopa and ultraviolet irradiation on melanogenesis. , 1968, Dermatologica.

[23]  S. Resnik.  Melasma induced by oral contraceptive drugs. , 1967, JAMA.

[24]  M. Pathak,et al.  The effect of a single dose of ultraviolet radiation on epidermal melanocytes. , 1965, The Journal of investigative dermatology.

[25]  W. C. Quevedo,et al.  Melanocyte populations in UV-irradiated human skin. , 1965, The Journal of investigative dermatology.

[26]  R. Snell.  THE PIGMENTARY CHANGES OCCURRING IN THE BREAST SKIN DURING PREGNANCY AND FOLLOWING ESTROGEN TREATMENT. , 1964, The Journal of investigative dermatology.

[27]  R. Staricco,et al.  QUANTITATIVE RESPONSE OF THE MELANOCYTES TO ULTRAVIOLET LIGHT. , 1963, The Journal of investigative dermatology.

[28]  E. J. Esoda.  Chloasma from Progestational Oral Contraceptives , 1963 .

[29]  J. Morris.  Physiologic control of conception with norethynodrel. Clinical experience. , 1961, American journal of obstetrics and gynecology.

[30]  T. Sternberg,et al.  A melanosis of the face ("chloasma"). , 1961, Archives of dermatology.

[31]  R. Snell,et al.  The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. , 1960, The Journal of investigative dermatology.

[32]  T. Fitzpatrick,et al.  Tyrosinase in human skin: demonstration of its presence and of its role in human melanin formation. , 1950, Science.